Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendationsResearch Article Published on 2020-07-152022-10-28 Journal: BMC Medicine [Category] COVID-19, SARS, [키워드] adjust alteration anticipated Care clinician complex coronavirus disease COVID-19 dose drug–drug interaction Drug–drug interactions events Evidence guideline higher risk IMPROVE infective Interaction International management medical treatment medical treatments medication methodology Novel coronavirus pandemic people with COVID-19 Psychiatric Psychiatric comorbidity psychiatric condition Psychopharmacology Psychotropic medication psychotropic medications public health emergency Rapid recommendation Result risk Safety the WHO Treatment vulnerable patients worsening [DOI] 10.1186/s12916-020-01685-9 PMC 바로가기 [Article Type] Research Article
The pandemic COVID-19: a tale of viremia, cellular oxidation and immune dysfunctionCase Study Published on 2020-07-152022-10-28 Journal: The Pan African Medical Journal [Category] COVID-19, MERS, SARS, [키워드] carrier caused cellular cellular oxidation Certain disease clinician combating COVID-19 expected Factor help immune immune dysfunction immune system immunomodulatory immunoprophylactic Infection measure modulate morbidity Mortality National pandemic reduced SARS-CoV-2 social distancing the disease the healthy the SARS-CoV-2 therapeutic agent Vaccine Viremia virulence while wild animal with COVID-19 [DOI] 10.11604/pamj.2020.36.188.23476 PMC 바로가기 [Article Type] Case Study
Association Between Diabetes and COVID-19: A Retrospective Observational Study With a Large Sample of 1,880 Cases in Leishenshan Hospital, WuhanEndocrinology Published on 2020-07-142022-10-31 Journal: Frontiers in Endocrinology [Category] COVID-19, MERS, SARS, [키워드] Analysis analyzed association Chest computed tomography Clinical course clinical courses Clinical symptoms clinician collected Comorbidity consecutive patient coronavirus disease Coronavirus disease 2019 (COVID-19) courses COVID-19 COVID-19 case COVID-19 patient Critical demographic data diabete Diabetes Mellitus diabetic patient enrolled follow-up period had no Kaplan-Meier curve Laboratory tests management Mild mortality rate multivariate Cox regression no difference outcome Patient patients with diabete percentage Prognosis Sample statistically significant difference suggested survival Treatment with COVID-19 Wuhan [DOI] 10.3389/fendo.2020.00478 PMC 바로가기 [Article Type] Endocrinology
Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, CanadaLetter Published on 2020-07-142022-10-29 Journal: Trials [Category] COVID-19, SARS, [키워드] 1:1 Activation age All participants anticipated baseline blinded block sizes blocked blood sample Canada Chloroquine circulating cirrhosis clinical clinician composite endpoint computer-generated Concomitant medication correlation Course COVID-19 COVID-19 negative criteria deficiency determine diabete diagnostic disease severity dissemination ECG element Encephalopathy endothelial Enrollment extension FIVE fixed Follow-up G6PD HCQ HCW Health care worker Hepatitis high risk hospital Hospitalization Hospitalized Host Hydroxychloroquine immune include individually randomized insulin intensive care units Intervention intervention arm intubation investigator Laboratory Liver disease Long marker microbiologically Mortality multisite neutralize non-invasive ventilation non-specific number objective offered Older open label Oropharyngeal outcome outcome measure parallel-group participant patients per day Placebo placebo-controlled plasma porphyria positive positive result pregnant Prevent Primary outcome Prophylaxis Protecting protocol Psychological distress psychological Impact QTc QTc interval randomised randomised placebo controlled trial reactive reduce Registered renal reported Research Respiratory failure risk of COVID-19 Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus secondary Seroconversion serology Standard status study period Study protocol Support symptom duration symptomatic syndrome Tablet tablets term Toronto Trial two group Two-arm undergo use of hydroxychloroquine ventilator viral PCR Viral RNA website worker [DOI] 10.1186/s13063-020-04577-8 PMC 바로가기 [Article Type] Letter
Laboratory abnormalities and risk factors associated with in‐hospital death in patients with severe COVID‐19Research Article Published on 2020-07-122022-10-30 Journal: Journal of Clinical Laboratory Analysis [Category] COVID-19, MERS, SARS, [키워드] abnormality Admission average Blood urea nitrogen C‐reactive protein clinician Coagulation parameters collected COVID‐19 cytokine Cytokine storm death enrolled greater help hospital hypersensitivity identify inflammation response Laboratory laboratory abnormality laboratory parameter males median age multiple organ failure Multivariable regression neutrophil count Older outbreak outcome outcomes Patient patients died Result risk factor Risk factors Severe patient significantly survivor the severe COVID‐19 Tongji Hospital Treatment Wuhan, China [DOI] 10.1002/jcla.23467 PMC 바로가기 [Article Type] Research Article
Extrapulmonary manifestations of COVID-19 Reviews Published on 2020-07-102022-10-05 Journal: Nature Medicine [Category] SARS, 바이오마커, 유전자 메커니즘, 임상, 치료제, [키워드] ACE2 acute coronary syndromes Acute kidney injury addition arrhythmia clinician complications condition contribute coronavirus SARS-CoV-2 COVID-19 dysregulation endothelial damage entry receptor expressed Extrapulmonary extrapulmonary tissues gastrointestinal symptoms hepatocellular injury hyperglycemia illnesses immune responses include Injury involved management manifestation Manifestations mechanism Myocardial dysfunction neurologic ocular organ system organ-specific pathology pathophysiology pathway patients with COVID-19 recognizing Research Symptoms therapeutic strategy Thromboinflammation Thrombotic complications tissue damage [DOI] 10.1038/s41591-020-0968-3 [Article Type] Reviews
Recurrent positive nucleic acid detection in a recovered COVID-19 patient: A case report and literature reviewCase report Published on 2020-07-102022-10-05 Journal: Respiratory Medicine Case Reports [Category] 치료기술, [키워드] analyzed Case report Clinical data clinician coronavirus disease COVID-19 COVID-19 patients discharge discharged literature review nucleic acid Nucleic acid detection objective Patient positive Recovering positive Recurrent Respiratory Coronavirus Result SARS-CoV-2 SARS-CoV-2 nucleic acid sputum the patient Treatment [DOI] 10.1016/j.rmcr.2020.101152 [Article Type] Case report
Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature reviewOriginal Article Published on 2020-07-092022-10-30 Journal: Neurological Sciences [Category] COVID-19, MERS, [키워드] acute respiratory syndrome AIDP cerebrospinal fluid clinical entities clinician coronavirus coronavirus disease correlation Course COVID-19 COVID-19 patient defined demyelinating described description Diagnosis distal etiological F wave gastrointestinal symptoms Guillain-Barrè latency less literature review lower limbs manifestation monophasic muscular neurological neurological manifestations Neuropathy Para-infectious Polyradiculoneuropathy positive reported respiratory responsible SARS-CoV-2 Support Swab Symptom syndrome tested the SARS-CoV-2 Trigger triggered virus weakness [DOI] 10.1007/s10072-020-04553-9 PMC 바로가기 [Article Type] Original Article
Telemedicine During the COVID-19 Pandemic: Impact on Care for Rare CancersOriginal Reports Published on 2020-07-082022-10-31 Journal: JCO Global Oncology [Category] Coronavirus, SARS, [키워드] Affect average Cancer Care changes in clinician Clinicians COVID-19 COVID-19 pandemic evaluate Health care system Impact indicated lack MOST outcome outpatient appointment pandemic Patient patients Patients with cancer performance status Physical examination questionnaire reduced remained Sarcoma Satisfaction Telemedicine therapy Travel unit widespread [DOI] 10.1200/GO.20.00220 PMC 바로가기 [Article Type] Original Reports
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus positionConsensus Statement Published on 2020-07-082022-10-28 Journal: British Journal of Cancer [Category] COVID-19, SARS, [키워드] approach Chemotherapy clinician Consensus coronavirus disease COVID-19 described diagnostic disease Europe Factor healthcare hospital incidence include limit management modify outcome Pancreatic cancer pandemic Pathways Patient Patients with cancer Precision priority Radiotherapy recommendation resource risk severity of COVID-19 significant delay standard treatment surgical resection Treatment treatment approaches USA [DOI] 10.1038/s41416-020-0980-x PMC 바로가기 [Article Type] Consensus Statement